Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-12-000229
Filing Date
2012-01-19
Accepted
2012-01-19 18:45:45
Documents
1
Period of Report
2012-01-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT c68179_form4.html 4  
1 OWNERSHIP DOCUMENT c68179_form4.xml 4 7536
  Complete submission text file 0000930413-12-000229.txt   9233
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854
Business Address
Conover Charles (Reporting) CIK: 0001538563 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 12535573